Summary

Lists findings about amyotrophic lateral sclerosis (ALS), describing the disease, typical progression (muscle weakness to paralysis), average life expectancy after diagnosis (2–5 years), prevalence and incidence estimates in the United States, diagnostic delays, higher diagnosis rates among U.S. military veterans, unknown causes in most cases, and burdens on patients and family caregivers. It notes there is no cure as of introduction. The text is a statement of findings and contains no funding, deadlines, statutory changes, agency directives, or other operative requirements; its primary effect is to raise awareness and record facts about ALS for lawmakers and the public.

• Declares ALS a progressive neurodegenerative disease that attacks motor neurons and commonly causes death from respiratory failure.
• States expected life expectancy after diagnosis is about 2–5 years.
• Provides U.S. prevalence/incidence estimates: tens of thousands living with ALS, >5,000 new diagnoses annually, ~15 diagnoses per day.
• Notes diagnostic delays often exceed one year from symptom onset.
• Reports up to 90% of cases have unknown causes; ~10% have known genetic causes.
• Highlights higher ALS diagnosis rates among U.S. military veterans.
• Recognizes heavy physical, emotional, and financial burdens on patients, spouses, children, and other family caregivers.
• Contains no funding, mandates, statutory changes, or agency directives—primarily informational.